Solid form changes during drug development: good, bad, and ugly case studies - AAPS open

The relevance of solid form in drug development has been well established over time. In order to fully understand drug properties, attention has been paid to solid state structure of drug molecules and their relationship to the drug formulation. While each drug developer has had their own strategies and workflows for screening and choosing solid forms of drug molecules, the industry is aware of instances where “the best laid plans” often go awry. This manuscript has summarized several case studies in development programs that display the “good, bad, and ugly” of solid form changes.

More

Download
Solid form changes during drug development: good, bad, and ugly case studies
Ann NewmanEmail author and Robert Wenslow
AAPS Open20162:2
DOI: 10.1186/s41120-016-0003-4© The Author(s) 2016
Received: 9 November 2015Accepted: 17 February 2016
art%3A10.1186%2Fs41120-016-0003-4.pdf
Adobe Acrobat Document 1.7 MB